Software AG

  • WKN: A2GS40
  • ISIN: DE000A2GS401
  • Land: Germany

Nachricht vom 01.04.2014 | 00:27

Software AG sells SAP-Service Operations in DACH region to strategic partner Scheer Group


Software AG  / Key word(s): Mergers & Acquisitions/Disposal

01.04.2014 00:27

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Software AG sells its SAP-Service Operations in the DACH region to its strategic partner, the Scheer Group - The Scheer Group acquires the SAP Consulting operations in Germany, Austria and Switzerland - Software AG and the Scheer Group agree on a strategic cooperation - The transaction concludes the consolidation of the SAP Consulting business Darmstadt, Germany, 31/3/2014 Software AG (Frankfurt TecDAX: SOW) today announced that an agreement with the Scheer Group GmbH (Saarbrucken, Germany) has been reached concerning the sale of its SAP-service operations in Germany, Austria and Switzerland (DACH region). The parties have agreed to maintain confidentiality with regard to the details of the agreement and the purchase price. The transaction is subject to approval of the respective fair trade offices and other customary closing conditions, and is expected to close in the second quarter of 2014. The transaction includes all of Software AG's SAP product-specific services in the region DACH bundled in its subsidiary IDS Scheer Consulting GmbH with some 500 employees and total revenue of some EUR64 million (FY 2013). With this step, Software AG will conclude the consolidation and transformation of the (non-core) SAP consulting business after having divested the operations in North America and Eastern Europe in 2013. The SAP consulting business was part of IDS Scheer AG which Software AG acquired in 2009 with the main focus on ARIS, the world leading business process analysis product portfolio. Software AG has fully integrated and further developed the ARIS product family which has become a vital and driving part of its fast growing product line Business Process Excellence (BPE). This business line already provides 60 percent of Software AG's product revenue and has showed significantly stronger growth than the market and its peers. Software AG and the Scheer Group have been partners in the German Software Cluster for more than five years and intend to extend their cooperation based on ARIS technology. ARIS is rated as the leading software for design and analysis of digital business processes and as of this year ARIS is also available in the cloud. The transaction is expected to have a neutral to slightly positive effect on stated EBIT (IFRS) for FY 2014 and will reduce the revenue and business line contribution of the consulting division. The company now expects for FY 2014 additional improvements of group profit margin and to increase operating result (non-IFRS) for FY 2014 by two to seven percent over the previous year. The financial results for Q1 2014 (IFRS, preliminary) will be released on May 2, 2014. 01.04.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: Software AG Uhlandstraße 12 64297 Darmstadt Germany Phone: +49 (0)6151 92-1900 Fax: +49 (0)6151 92-34 1899 E-mail: Investor.Relations@softwareag.com Internet: www.softwareag.com ISIN: DE0003304002 WKN: 330400 Indices: TecDAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021